254 related articles for article (PubMed ID: 29185803)
1. Better Tolerance of Citalopram in a Breastfed Infant Who Could Not Tolerate Sertraline and Paroxetine.
Uguz F
Breastfeed Med; 2018; 13(1):89-90. PubMed ID: 29185803
[TBL] [Abstract][Full Text] [Related]
2. [The transfer of selective serotonin reuptake inhibitors to human milk].
Nordeng H; Bergsholm YK; Bøhler E; Spigset O
Tidsskr Nor Laegeforen; 2001 Jan; 121(2):199-203. PubMed ID: 11475200
[TBL] [Abstract][Full Text] [Related]
3. Short-Term Safety of Paroxetine Plus Low-Dose Mirtazapine During Lactation.
Uguz F
Breastfeed Med; 2019 Mar; 14(2):131-132. PubMed ID: 30489153
[TBL] [Abstract][Full Text] [Related]
4. Short-Term Safety of Paroxetine and Sertraline in Breastfed Infants: A Retrospective Cohort Study from a University Hospital.
Uguz F; Arpaci N
Breastfeed Med; 2016 Nov; 11():487-489. PubMed ID: 27575664
[TBL] [Abstract][Full Text] [Related]
5. Breastfeeding during maternal antidepressant treatment with serotonin reuptake inhibitors: infant exposure, clinical symptoms, and cytochrome p450 genotypes.
Berle JØ; Steen VM; Aamo TO; Breilid H; Zahlsen K; Spigset O
J Clin Psychiatry; 2004 Sep; 65(9):1228-34. PubMed ID: 15367050
[TBL] [Abstract][Full Text] [Related]
6. Switching patients from daily citalopram, paroxetine, or sertraline to once-weekly fluoxetine in the maintenance of response for depression.
Miner CM; Brown EB; Gonzales JS; Munir R
J Clin Psychiatry; 2002 Mar; 63(3):232-40. PubMed ID: 11926723
[TBL] [Abstract][Full Text] [Related]
7. Use of contemporary antidepressants during breastfeeding: a proposal for a specific safety index.
Gentile S
Drug Saf; 2007; 30(2):107-21. PubMed ID: 17253877
[TBL] [Abstract][Full Text] [Related]
8. Antidepressant medication use during breastfeeding.
Lanza di Scalea T; Wisner KL
Clin Obstet Gynecol; 2009 Sep; 52(3):483-97. PubMed ID: 19661763
[TBL] [Abstract][Full Text] [Related]
9. Incidence of early anxiety aggravation in trials of selective serotonin reuptake inhibitors in depression.
Näslund J; Hieronymus F; Emilsson JF; Lisinski A; Nilsson S; Eriksson E
Acta Psychiatr Scand; 2017 Oct; 136(4):343-351. PubMed ID: 28859218
[TBL] [Abstract][Full Text] [Related]
10. Use of sertraline, paroxetine and fluvoxamine by nursing women.
Hendrick V; Fukuchi A; Altshuler L; Widawski M; Wertheimer A; Brunhuber MV
Br J Psychiatry; 2001 Aug; 179():163-6. PubMed ID: 11483479
[TBL] [Abstract][Full Text] [Related]
11. A comparative review of escitalopram, paroxetine, and sertraline: Are they all alike?
Sanchez C; Reines EH; Montgomery SA
Int Clin Psychopharmacol; 2014 Jul; 29(4):185-96. PubMed ID: 24424469
[TBL] [Abstract][Full Text] [Related]
12. Serotonin reuptake inhibitors and breastfeeding: a systematic review.
Orsolini L; Bellantuono C
Hum Psychopharmacol; 2015 Jan; 30(1):4-20. PubMed ID: 25572308
[TBL] [Abstract][Full Text] [Related]
13. Citalopram and breast-feeding: serum concentration and side effects in the infant.
Schmidt K; Olesen OV; Jensen PN
Biol Psychiatry; 2000 Jan; 47(2):164-5. PubMed ID: 10664835
[TBL] [Abstract][Full Text] [Related]
14. Sertraline, citalopram and paroxetine in lactation: passage into breastmilk and infant exposure.
Den Besten-Bertholee D; Touw DJ; Damer EA; Mian P; Ter Horst PGJ
Front Pharmacol; 2024; 15():1414677. PubMed ID: 38841362
[TBL] [Abstract][Full Text] [Related]
15. Maternal fluoxetine treatment in the postpartum period: effects on platelet serotonin and plasma drug levels in breastfeeding mother-infant pairs.
Epperson CN; Jatlow PI; Czarkowski K; Anderson GM
Pediatrics; 2003 Nov; 112(5):e425. PubMed ID: 14595087
[TBL] [Abstract][Full Text] [Related]
16. Maternal sertraline treatment and serotonin transport in breast-feeding mother-infant pairs.
Epperson N; Czarkowski KA; Ward-O'Brien D; Weiss E; Gueorguieva R; Jatlow P; Anderson GM
Am J Psychiatry; 2001 Oct; 158(10):1631-7. PubMed ID: 11578995
[TBL] [Abstract][Full Text] [Related]
17. Differential Associations of Specific Selective Serotonin Reuptake Inhibitors With Resting-State Heart Rate and Heart Rate Variability: Implications for Health and Well-Being.
Kemp AH; Fráguas R; Brunoni AR; Bittencourt MS; Nunes MA; Dantas EM; Andreão RV; Mill JG; Ribeiro AL; Koenig J; Thayer JF; Benseñor IM; Lotufo PA
Psychosom Med; 2016 Sep; 78(7):810-8. PubMed ID: 27219492
[TBL] [Abstract][Full Text] [Related]
18. Persistence, switching, and discontinuation rates among patients receiving sertraline, paroxetine, and citalopram.
Mullins CD; Shaya FT; Meng F; Wang J; Harrison D
Pharmacotherapy; 2005 May; 25(5):660-7. PubMed ID: 15899727
[TBL] [Abstract][Full Text] [Related]
19. Gastrointestinal Side Effects in the Baby of a Breastfeeding Woman Treated with Low-Dose Fluvoxamine.
Uguz F
J Hum Lact; 2015 Aug; 31(3):371-3. PubMed ID: 25896469
[TBL] [Abstract][Full Text] [Related]
20. What are the risks associated with different Selective Serotonin Re-uptake Inhibitors (SSRIs) to treat depression and anxiety in pregnancy? An evaluation of current evidence.
Womersley K; Ripullone K; Agius M
Psychiatr Danub; 2017 Sep; 29(Suppl 3):629-644. PubMed ID: 28953843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
